Quarterly report [Sections 13 or 15(d)]

Acquisition of CorHepta (Tables)

v3.25.2
Acquisition of CorHepta (Tables)
 6 Months Ended
Jun. 30, 2025
Business Combination [Abstract]  
Schedule of fair value of consideration transferred

The fair value of consideration transferred was determined as follows:

 

 

 

Shares

 

 

Share Price at Closing

 

 

Fair Value at Acquisition
February 21, 2025

 

Fully vested shares

 

 

829,849

 

 

$

2.97

 

 

$

2,464,652

 

Contingent consideration

 

 

1,493,415

 

 

 

2.97

 

 

 

4,435,443

 

Transaction costs incurred by the Company

 

 

 

 

 

 

 

 

438,624

 

Fair value of consideration

 

 

 

 

 

 

 

$

7,338,719

 
Schedule of allocation of consideration transferred

The allocation of consideration transferred is as follows:

Acquired IPR&D

 

$

7,357,294

 

Cash

 

 

49,633

 

Current liabilities

 

 

(68,208

)

Fair value of consideration

 

$

7,338,719